Our Vision

OUR VISION

Translational Research

Bridging lab to clinic

Nanocarriers

Smart delivery systems

Microfluidics & Organ-on-Chip

Simulating cancer microenvironments with precision flow

Breast Organoids

Mimicking real tissues

Screening Platforms

From concept to readout

Advanced In Vitro Models

Next-gen tools to decode tumor complexity

Shaping the Future of 3D-Based Therapeutics against Breast Cancer

Breast cancer remains one of the most prevalent and impactful diseases worldwide. Each year, over 2 million new cases are diagnosed, with hundreds of thousands of lives lost despite decades of research and therapeutic progress. As a global health challenge, breast cancer has galvanized efforts across scientific, medical, and technological domains — leading to groundbreaking discoveries in genetics, imaging, targeted therapies, and early detection.

In recent years, we’ve entered an era of precision oncology. Molecular subtyping, predictive biomarkers, and targeted therapeutics have revolutionized breast cancer care. Yet, even amidst this progress, a critical bottleneck remains: the translation of promising laboratory findings into safe and effective clinical treatments. The stark reality is that 95% of oncology drugs fail during clinical trials , often because the preclinical models used to test them (such as traditional 2D cell cultures) do not adequately reflect the complexity of human disease.
At ZetaBio Group, we believe the future of breast cancer therapeutics lies in more physiologically relevant preclinical platforms — models that better capture the intricate architecture, signaling, and microenvironment of tumors. Three-dimensional (3D) cultures, spheroids, and organoids offer this potential. By mimicking key features of in vivo tissues, these models allow us to observe drug responses with greater fidelity and nuance.
We are committed to leveraging these advanced cellular platforms, not just as passive testing grounds, but as interactive systems where novel nanodrugs and smart delivery vehicles can be evaluated, optimized, and understood. Our focus spans from drug formulation and encapsulation strategies to the behavior of these compounds within complex cellular environments. Through this, we aim to support the development of more selective, efficient, and personalized therapies for breast cancer.
But we also recognize that science thrives in collaboration. Our vision includes the creation of an open, evolving network of researchers, clinicians, institutions, and innovators. We actively invite contributors to co-write scientific articles based on pre-defined themes, and we hope to support the formation of thematic subgroups that may grow into future research consortia. For those teams demonstrating strong alignment and capacity, we aim to move toward grant writing and proposal development, always with a focus on meaningful, translational impact.

Ultimately, ZetaBio Group aspires to be more than a project: to become a platform for scientific growth, where knowledge exchange, ethical collaboration, and experimental innovation converge. Through this journey, we hope not only to accelerate breast cancer research but also to build the foundations for a sustainable, mission-driven enterprise that nurtures discovery, talent, and impact.

Together, we shape what’s next.

Emergency Symptoms

Egestas phasellus hac proin fringilla dis sed etiam purus aenean sed ut neque, sed enim in mollis auctor turpis dapibus sit tristique et malesuada aliquet vitae sagittis sollicitudin dui lectus massa elementum.

What we offer

Common Symptoms

Risus pulvinar aliquam ut nullam sapien quam aliquam sodales suspendisse maecenas libero cursus imperdiet scelerisque elementum faucibus ultricies eu eleifend vulputate molestie nunc ullamcorper vulputate semper in id sed habitasse ornare nisl

Emergency Symptoms

Egestas phasellus hac proin fringilla dis sed etiam purus aenean sed ut neque, sed enim in mollis auctor turpis dapibus sit tristique et malesuada aliquet vitae sagittis sollicitudin dui lectus massa elementum.

What We’re Looking For

A leo, morbi tempus, maecenas egestas felis pretium eget semper orci molestie id et volutpat egestas fermentum facilisis vitae semper nunc nec, neque est:

Risus pulvinar aliquam ut nullam sapien quam aliquam sodales suspendisse maecenas libero cursus imperdiet scelerisque elementum faucibus ultricies eu eleifend vulputate molestie nunc ullamcorper vulputate semper in id sed habitasse ornare nisl.

We welcome diverse expertise and levels of experience:

02.

Biomedical Engineers & Biotechnologists

Create and refine organ-on-a-chip systems and microfluidic platforms.

They integrate engineering with biology to simulate tissue environments and improve in vitro models.